Cargando…
Economic Impact of the Application of a Precision Medicine Model (5SPM) on Psychotic Patients
BACKGROUND: Schizophrenia is a severe mental disorder that often manifests within the first three decades of life. Its prognosis is uncertain and may result in a prolonged treatment that could extend throughout the entire lifespan of the patient. Antipsychotic drugs are characterized by a high inter...
Autores principales: | Carrascal-Laso, Lorena, Franco-Martín, Manuel Ángel, Marcos-Vadillo, Elena, Ramos-Gallego, Ignacio, García-Berrocal, Belén, Mayor-Toranzo, Eduardo, Sánchez-Iglesias, Santiago, Lorenzo, Carolina, Sevillano-Jiménez, Alfonso, Sánchez-Martín, Almudena, García-Salgado, María Jesús, Isidoro-García, María |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8379643/ https://www.ncbi.nlm.nih.gov/pubmed/34429634 http://dx.doi.org/10.2147/PGPM.S320816 |
Ejemplares similares
-
Application of a Pharmacogenetics-Based Precision Medicine Model (5SPM) to Psychotic Patients That Presented Poor Response to Neuroleptic Therapy
por: Carrascal-Laso, Lorena, et al.
Publicado: (2020) -
Case Report: Pharmacogenetics Applied to Precision Psychiatry Could Explain the Outcome of a Patient With a New CYP2D6 Genotype
por: Marcos-Vadillo, Elena, et al.
Publicado: (2022) -
Review: Influence of the CYP450 Genetic Variation on the Treatment of Psychotic Disorders
por: Carrascal-Laso, Lorena, et al.
Publicado: (2021) -
Ten Years of Experience Support Pharmacogenetic Testing to Guide Individualized Drug Therapy
por: Peña-Martín, María Celsa, et al.
Publicado: (2022) -
Role of Pharmacogenetics in Improving the Safety of Psychiatric Care by Predicting the Potential Risks of Mania in CYP2D6 Poor Metabolizers Diagnosed With Bipolar Disorder
por: Sánchez-Iglesias, Santiago, et al.
Publicado: (2016)